MintLean R·
Drugmakers may need designated expert to certify batches before sale
The development assumes significance for India's $60-billion pharmaceutical industry amid concerns over the quality of drugs manufactured in the country.
Read at Mint →
The development assumes significance for India's $60-billion pharmaceutical industry amid concerns over the quality of drugs manufactured in the country.

<iframe src="https://hindustansphere.com/embed/cluster/0695a1341ef833cccd218d68adabd892f6f4a577" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Drugmakers may need designated expert to certify batches before sale"></iframe>
The development assumes significance for India's $60-billion pharmaceutical industry amid concerns over the quality of drugs manufactured in the country.

